Champlain Investment Partners, LLC Axonics, Inc. Transaction History

Champlain Investment Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $58 Million - $71 Million	-1,023,225 Reduced 53.37%	893,908 $61.7 Million
Q4 2023 Feb 13, 2024	SELL	$49.38 - $63.75 $4.75 Million - $6.14 Million	-96,268 Reduced 4.78%	1,917,133 $119 Million
Q3 2023 Nov 13, 2023	BUY	$48.64 - $62.51 $13.2 Million - $17 Million	272,006 Added 15.62%	2,013,401 $113 Million
Q2 2023 Aug 11, 2023	BUY	$47.99 - $60.21 $19.4 Million - $24.4 Million	404,550 Added 30.26%	1,741,395 $87.9 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $13.1 Million - $16.8 Million	249,595 Added 22.96%	1,336,845 $72.9 Million
Q4 2022 Feb 13, 2023	BUY	$59.56 - $76.6 $12.2 Million - $15.7 Million	204,660 Added 23.19%	1,087,250 $68 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $12.1 Million - $16.3 Million	-209,005 Reduced 19.15%	882,590 $62.2 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $3.86 Million - $6.3 Million	97,760 Added 9.84%	1,091,595 $61.9 Million
Q1 2022 May 12, 2022	BUY	$43.74 - $62.76 $12.7 Million - $18.3 Million	291,045 Added 41.41%	993,835 $62.2 Million
Q4 2021 Feb 10, 2022	BUY	$50.01 - $73.35 $18.7 Million - $27.4 Million	374,160 Added 113.85%	702,790 $39.4 Million
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $19.5 Million - $25.9 Million	328,630 New	328,630 $21.4 Million

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.